Other News

Cleerly Expands Executive Team With Appointment of New Chief Operating Officer and Chief Technology Officer

Brandon Atkinson joins as COO and Nick Nieslanik as CTO to Support Company’s Mission to Create a New Standard of Care for Heart Disease, the Leading Cause of Death. NEW YORK–(BUSINESS WIRE)–Cleerly, the company creating a new standard of care for heart disease, announced today it has appointed Brandon Atkinson […]

Surmodics Announces Successful First Patient Uses of Sublime™ Radial Access .018 RX PTA Dilatation Catheter

Latest addition to the Sublime™ Radial Access Platform expands market opportunity by increasing size offering to treat larger vessels and providing the shaft length needed to treat more distal lesions using a radial approach EDEN PRAIRIE, Minn.–(BUSINESS WIRE)–Surmodics, Inc. (NASDAQ:SRDX), a leading provider of medical device and in vitro diagnostic […]

AstraZeneca Healthcare Foundation Awards Seven US Nonprofits More Than $900k to Improve Heart Health and Advance Health Equity

WILMINGTON, Del.–(BUSINESS WIRE)–Today on World Heart Day, the AstraZeneca HealthCare Foundation has awarded seven innovative, community-based nonprofit organizations $954,311 in grants across seven US states to address cardiovascular disease, a leading cause of death in the nation. The grants are part of the Foundation’s signature Connections for Cardiovascular HealthSM (CCH) Next Generation program, now in […]

FDA Clears Caretaker Medical’s Wireless Platform for Continuous Noninvasive Blood Pressure and Hemodynamic Monitoring

Innovative Next-Generation Technology Monitors the Most Important Vital Signs for Cardiovascular Health CHARLOTTESVILLE, Va.–(BUSINESS WIRE)–Caretaker Medical, a pioneer in wireless “beat by beat” continuous, non-invasive, advanced patient monitoring, today announced U.S. Food and Drug Administration (FDA) clearance of the company’s next-generation VitalStream™ wireless blood pressure and hemodynamic monitoring platform. Continuous […]

Endologix Initiates Randomized Study of ALTO® Abdominal Stent Graft System

JAGUAR Study Evaluates ALTO Compared to Other Commercially Available EVAR Devices IRVINE, Calif.–(BUSINESS WIRE)–Endologix LLC, a leader in the treatment of vascular disease, today announced that the first patient has been enrolled in the company’s JAGUAR study to compare outcomes for the company’s ALTO® Abdominal Stent Graft System to other commercially […]

Vascular Quality Initiative and Symmetric Health Solutions Partner to Improve Medical Device Identification Accuracy

Organizations will work together to eliminate variances and data discrepancies and ensure hospitals meet FDA reporting requirements CHICAGO–(BUSINESS WIRE)–The Society for Vascular Surgery® Vascular Quality Initiative® (SVS VQI), a nonprofit organization dedicated to improving vascular quality within hospitals and outpatient facilities, today announced its partnership with Symmetric Health Solutions, for the purpose of […]

Medtronic Receives CE Mark Approval for Radial Artery Access Portfolio

– Portfolio Features First Catheter Specifically Designed to Allow Neurointerventionalists Radial Artery Access, Delivers Advantages to Patients Treated for Stroke, Brain Aneurysms, Other Neurovascular Conditions – Now Available in the United Kingdom, Italy, Spain, Germany and France DUBLIN, Sept. 28, 2021 /PRNewswire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, today […]

Open Stent Solution closes €2.5M Seed financing round for its breakthrough open-stent TMVR device

AMIENS, France, Sept. 28, 2021 /PRNewswire/ — Open Stent Solution (OSS), a medtech start-up company developing the first open-stent heart valves, today announced the closing of a €2.5 million Seed financing round. The funding will support the development of its ribbon-shaped stented mitral valve for transcatheter replacement. OSS’ breakthrough device is the first-ever […]

Foldax Completes Enrollment in Early Feasibility Study for TRIA Biopolymer Surgical Aortic Heart Valve

SALT LAKE CITY–(BUSINESS WIRE)–Foldax®, Inc. today announced completion of enrollment in the U.S. early feasibility study of the TRIA™ surgical aortic heart valve. The TRIA valve reimagines the heart valve by combining the company’s proprietary biopolymer – LifePolymer™ – with an innovative valve design intended to resist calcification, withstand stresses […]

Neovasc REDUCER-I Study Published in EuroIntervention Journal

VANCOUVER and MINNEAPOLIS, Sept. 28, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today announced the publication of an article entitled, “Coronary sinus narrowing for the treatment of refractory angina: a multicentre prospective open-label clinical study (the REDUCER-I study)” in the September 2021 issue of the journal EuroIntervention. […]